PURCHASE, N. Y., March 11, 2024 Cognition Therapeutics, Inc. , a clinical stage company developing product candidates designed to treat neurodegenerative disorders, today announced that it has.
21.02.2024 - SAN DIEGO, CA / ACCESSWIRE / February 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ( Modular Medical or the Company ), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable . Seite 1
SAN DIEGO, CA / ACCESSWIRE / February 21, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a development stage insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, announced today the closi.